Efficient generation of canine bone marrow-derived dendritic cells.

Area of Science:

• Immunology
• Veterinary Medicine
• Cell Biology

Background:

• Dendritic cells are crucial for initiating T cell responses and are candidates for immunotherapy.
• Limited data exists on canine dendritic cell generation and function, hindering clinical applications.

Purpose of the Study:

• To establish an efficient protocol for generating canine dendritic cells from bone marrow.
• To characterize the phenotype and function of these generated canine dendritic cells.

Main Methods:

• Bone marrow-derived cells were cultured using recombinant feline granulocyte-macrophage colony-stimulating factor and canine interleukin-4.
• Generated cells were analyzed for morphology, surface marker expression (MHC class II, CD11c), and response to lipopolysaccharide stimulation.
• Functional assays included phagocytosis, protein processing, and allogeneic T cell activation.

Main Results:

• An efficient protocol yielded 1-9 x 10^6 dendritic cells per 0.5 ml bone marrow aspirate.
• Canine dendritic cells exhibited dendrite morphology and expressed MHC class II and CD11c.
• Activated dendritic cells showed upregulated antigen presentation molecules and potent T cell activation compared to macrophages.

Conclusions:

• Bone marrow-derived canine dendritic cells can be efficiently generated and possess functional characteristics similar to human and mouse dendritic cells.
• These cells are capable of capturing and processing antigens and initiating T cell responses.
• The findings support the potential of canine dendritic cells in developing novel immunotherapeutic strategies for dogs.